Literature DB >> 1749212

Interrelationships of liver and brain with special reference to Reye syndrome.

J K Brown1, H Imam.   

Abstract

Reye syndrome is an acute non-inflammatory encephalopathy that can be precipitated by toxic, infective, metabolic or hypoxic upsets. The biochemical changes point to mitochondrial dysfunction and this is substantiated by structural changes in mitochondria on electron microscopy. The toxic metabolites that accumulate are similar to those incriminated in hepatic encephalopathy and other metabolic diseases. These metabolites exert their deleterious effects by direct neuronal damage, neurotransmitter blockade, vascular damage, cerebral oedema, hypoxic ischaemic damage, demyelination, retardation of brain growth and neuronal storage. Brain capillary endothelial cells are very rich in mitochondria and mitochondrial disorders can effect the central nervous system primarily, and not just as a consequence of systemic metabolic upset.

Entities:  

Mesh:

Year:  1991        PMID: 1749212     DOI: 10.1007/bf01797917

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  81 in total

1.  ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA. A DISEASE ENTITY IN CHILDHOOD.

Authors:  R D REYE; G MORGAN; J BARAL
Journal:  Lancet       Date:  1963-10-12       Impact factor: 79.321

2.  Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance.

Authors:  J STAHL
Journal:  Ann Intern Med       Date:  1963-01       Impact factor: 25.391

3.  Uptake of ammonia by muscle; its implications in ammoniagenic coma.

Authors:  S P BESSMAN; J E BRADLEY
Journal:  N Engl J Med       Date:  1955-12-29       Impact factor: 91.245

4.  Brain stem haemorrhages in expanding supratentorial conditions.

Authors:  R T JOHNSON; P O YATES
Journal:  Acta radiol       Date:  1956 Jul-Aug       Impact factor: 1.990

5.  The astrocyte response in experimental portal-systemic encephalopathy: an electron microscopic study.

Authors:  M D Norenberg; L W Lapham
Journal:  J Neuropathol Exp Neurol       Date:  1974-07       Impact factor: 3.685

6.  Systemic carnitine deficiency simulating Reye syndrome.

Authors:  P M Coates; D E Hale; C A Stanley; A M Glasgow
Journal:  J Pediatr       Date:  1984-10       Impact factor: 4.406

7.  Short chain fatty acid inhibition of rat brain Na-K adenosine triphosphatase.

Authors:  D R Dahl
Journal:  J Neurochem       Date:  1968-08       Impact factor: 5.372

8.  Margosa oil poisoning as a cause of Reye's syndrome.

Authors:  D Sinniah; G Baskaran
Journal:  Lancet       Date:  1981-02-28       Impact factor: 79.321

9.  Medium-chain acyl-CoA dehydrogenase deficiency in two siblings with a Reye-like syndrome.

Authors:  P F Bougnères; F Rocchiccioli; S Kølvraa; M Hadchouel; J Lalau-Keraly; J L Chaussain; S K Wadman; N Gregersen
Journal:  J Pediatr       Date:  1985-06       Impact factor: 4.406

10.  Changes in brain catecholamine levels in human cirrhotic hepatic encephalopathy.

Authors:  G Cuilleret; G Pomier-Layrargues; F Pons; J Cadilhac; H Michel
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

View more
  2 in total

1.  Reye's syndrome with cortical laminar necrosis: MRI.

Authors:  T Kinoshita; S Takahashi; K Ishii; S Higano; K Matsumoto; K Sakamoto; K Haginoya; K Iinuma
Journal:  Neuroradiology       Date:  1996-04       Impact factor: 2.804

Review 2.  Is oral L-acyl-carnitine an effective therapy for hepatic encephalopathy? Review of the literature.

Authors:  Nathan J Shores; Emmet B Keeffe
Journal:  Dig Dis Sci       Date:  2008-02-14       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.